Objective: To understand the current situation of the consultation for outpatients with severe eye disease in
Zhongshan Ophthalmic Center, and to explore the distribution and effects of sub-specialty consultation for
outpatients with severe eye disease. To set up a scientific system of the consultation for outpatients with severe
eye disease, and also provide a basis for reasonable arrangement of consultation process. Methods: We analyzed 265 severe cases from March 2016 to April 2017 in Zhongshan Ophthalmic Center by time, region, gender, age,
cause of consultation, sub-specialty, and outcomes after consultation. And all data was analyzed by Excel software,
according to the purpose and the type of data, and the corresponding statistical index and statistical inference,
inspection level for α=0.05. Results: There were 265 cases with severe eye disease from March 2016 to April 2017.
As for the regional distribution, Guangdong province was the largest, with 145 cases, while the lowest number was
from foreign countries, which was 3 cases. In the population distribution, 167 cases were males, 98 were females
and the ratio was 1.70. In age distribution, patients aged from 30 to 44 years and 45 to 59 years predominated
and the number of cases were both 53, accounting for 20% of the total number. Patients over 70 were the least
which were 13 cases, accounting for 4.9% of the total number. From March 2016 to April 2017, all sub-specialties
attended consultation for 714 times, as Ocular Fundus Department attended the most, accounting for 20.5% of
the total number while Conjunctive Department attended the least, for only one, accounting for 0.1% of the total
number. As for the reason of the consultation, the number of cases involving multiple specialties was the largest,
with 161 cases, while the lowest number of cases due to unexplained causes, which were 20 cases. The number
of cases of explicit treatment was increased by 190 after consultation. Conclusion: Consultations organized by
Zhongshan Ophthalmic Center improves the treatment for outpatients with severe eye disease.